Raffles Medical Group (RMG)

Results

Raffles Medical Group's 3Q18 earnings come in flat at $16.4 mil

SINGAPORE (Oct 29): Raffles Medical Group (RMG) posted $16.4 million in earnings for the 3Q ended Sept, unchanged from a year ago on higher expenses.

Broker's Calls

Raffles Medical's China Taiping partnership to benefit in China, Singapore

SINGAPORE (Sept 25): Raffles Medical Group last month signed an MoU with China Taiping Insurance Group (CTIG) to jointly provide medical insurance solutions as well as healthcare management services and explore health-linked property opportunities.

Broker's Calls

Raffles Medical eyes expansion on insurance front as medical tourism prospects stay weak

SINGAPORE (Aug 7): Raffles Medical Group recently obtained regulatory approvals to enter into the Integrated Shield market, officially launching Raffles Shield, on Aug 1.

Results

Raffles Medical 2Q earnings kept steady at $16.9 mil; health insurance products to be another growth factor

SINGAPORE (Aug 6): Raffles Medical Group's expansion into mass market health insurance products will be another growth factor for the group, says executive chairman Dr Loo Choon Yong.

Singapore-listed healthcare stocks up 9.2% YTD as they gun for growth

SINGAPORE (May 23): Stocks of the 15 largest Singapore-listed healthcare equipment and services companies with market caps above $100 million, have gained an average 9.2% year to date, according to data from the Singapore Exchange.

Broker's Calls

Launch of Raffles Medical's China hospitals a step closer to reality

SINGAPORE (May 3): OCBC is reiterating its “buy” recommendation on Raffles Medical with a fair value estimate of $1.26.

Results

Raffles Medical posts 1.7% rise in 1Q earnings to $15.8 mil

SINGAPORE (Apr 30): Raffles Medical Group posts a 1.7% increase in earnings to $15.8 million for the 1Q ended March, from $15.5 million a year ago.

Broker's Calls

Insurance co-pay seen to have little near-term impact on Raffles Medical

SINGAPORE (Mar 13): UOB KayHian is maintaining Raffles Medical Group at "buy" given it sees limited impact on the stock from changes in insurance co-pay terms for new policies.

Broker's Calls

This healthcare stock's FY18 growth potential is keeping analysts upbeat

SINGAPORE (Feb 27): OCBC Investment Research, Phillip Capital and UOB Kay Hian are maintaining their “buy” calls on Raffles Medical Group with a fair value estimate and target prices of $1.26, $1.32 and $1.32 respectively.

Results

Raffles Medical reports 0.8% rise in FY17 earnings to $70.8 mil

SINGAPORE (Feb 26): Raffles Medical Group reported a 0.8% rise in FY17 earnings to $70.8 million from $70.2 million a year ago.
×